Psychiatric and substance use comorbidity among treatment-seeking opioid abusers

Archives of General Psychiatry

Volumn 54, Issue 1, 1997, Pages 71-80

  Brooner, Robert K ^a,b   King, Van L ^a   Kidorf, Michael ^a   Schmidt, Chester W ^a   Bigelow, George E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHADONE; OPIATE;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHADONE TREATMENT; OPIATE ADDICTION; PSYCHOSOCIAL DISORDER; SUBSTANCE ABUSE;

EID: 0031012763     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830130077015     Document Type: Article

References (86)

1. Group for the Advancement of Psychiatry. Substance abuse disorders: a psychiatric riority. Am J Psychiatry. 1991;148:1291-1300.
2. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch Gen Psychiatry. 1982;39:151-156.
3. Woody GE, Luborsky L, McLellan AT, O'Brien CP, Beck AT, Blaine J, Herman I, Hole A. Psychotherapy for opiate addicts. Arch Gen Psychiatry. 1983;40:636-645.
4. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry. 1985;42:1081-1086.
5. Schuckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry. 1985;42:1043-1049.
6. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. Arch Gen Psychiatry. 1986;43:739-745.
7. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987;44:505-513.
8. Nace EP, Davis CW, Gaspari JP. Axis II comorbidity in substance abusers. Am J Psychiatry. 1991;148:118-120.
9. Rounsaville BJ, Anton SF, Carroll K, Budde D, Brigitte AP, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48:43-51.
10. Rutherford MJ, Cacciola JS, Alterman AI. Relationships of personality disorders with problem severity in methadone patients. Drug Alcohol Depend. 1994;35:69-76.
11. Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers M, Feiner C, Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-979.
12. Des Jarlais DC, Friedman SR, Novick DM, Sotheran JL, Thomas P, Yancovitz SR, Mildvan D, Weber J, Kreek MJ, Maslansky R, Bartime S, Spira T, Marmor M. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261:1008-1012.
13. Nemoto T, Brown LS, Foster K, Chu A. Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive intervention. AIDS Educ Prev. 1990;2:116-126.
14. Haverkos HW, Lange WR. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis. 1990;161:894-902.
15. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF. The Alive Study: A longitudinal study of HIV-1 infection in intravenous drug users: description of methods. Drug Issues. 1991;21:759-776.
16. Metzger D, Woody GE, DePhilippis D, McLellan AT, O'Brien CP, Platt J. Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry. 1991;148:641-643.
17. Bass JB. Tuberculosis in the 1990s. Alcohol Clin Exp Res. 1995;19:3-5.
18. Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995;155:1305-1311.
19. Rounsaville BJ, Weissman MM, Kleber, H, Wilber, C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry. 1982;39:161-166.
20. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry. 1985;42:1067-1071.
21. Robins LN, Hezer JE, Weissman MM, Orvaschel H, Gruenbert E, Burke JD Jr, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1985;41:949-958.
22. Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179:215-221.
23. Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD. Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse. 1986;12:1-16.
24. Kolar AF, Brown BS, Weddington WW, Ball JC. A treatment crisis: cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat. 1990;7:101-107.
25. Strain EC, Brooner RK, Bigelow GE. Clustering of multiple substance use and psychiatric diagnoses in opiate addicts. Drug Alcohol Depend. 1991;27:127-134.
26. Kosten TR, Morgan C, Falcione J, Schottenfeld R. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry. 1992;49:894-898.
27. Kidorf M, Stitzer ML. Descriptive analysis of cocaine use in methadone patients. Drug Alcohol Depend. 1993;32:267-275.
28. Darke S, Hall W, Ross M, Wodak A. Benzodiazepine use and HIV risk-taking behavior among injecting drug users. Drug Alcohol Depend. 1992;31:31-36.
29. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend. 1993;32:257-266.
30. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
31. Spitzer SL, Williams JBW, Gibbon M, First MB. The Structured Clinical interview for DSM-III-R (SCID). Arch Gen Psychiatry. 1992;49:624-629.
32. Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Jowes MJ, Kane J, Pope HG Jr, Rounsaville BJ, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID), II: multisite test-retest reliability. Arch Gen Psychiatry. 1992;49:630-636.
33. Perry JC. Problems and considerations in the valid assessment of personality disorders. Am J Psychiatry. 1992;149:1645-1653.
34. Costa PT, McCrae RR. The NEO Personality Inventory Manual. Odessa, Fla: Psychological Assessment Resources; 1985.
35. Costa PT, McCrae RR. The NEO-PI/NEO-FFI Manual Supplement. Odessa, Fla: Psychological Assessment Resources: 1989.
36. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
37. McCrae RR, Costa PT. Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol. 1987;52:81-90.
38. Leong FTL, Dollinger SJ. NEO Personality Inventory. In: Keyser DJ, Sweetland RC, eds. Test Critiques. Austin, Tex: PRO-ED; 1990;527-539.
39. Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the Addiction Severity Index. J Nerv Ment Dis. 1983;171:606-610.
40. McLellan AT, Luborsky LK, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments. Arch Gen Psychiatry. 1983;40:620-625.
41. Holland BS, Copenhaver MD. Improved Bonferroni-type multiple testing procedures. Psychol Bull. 1988;104:145-149.
42. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
43. Kosten TR, Rounsaville BJ, Kleber HD. DSM-III personality disorders in opiate addicts. Compr Psychiatry. 1982;23:572-581.
44. Bryant KJ, Rounsaville BJ, Spitzer RL, Williams JB. Reliability of dual diagnosis. J Nerv Ment Dis. 1992;180:251-257.
45. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between 'substance-induced' and 'independent' depression and anxiety disorder. Am J Addict. 1995;4:107-117.
46. Rounsaville BJ, Kleber HD. Untreated opiate addicts: how do they differ from those seeking treatment? Arch Gen Psychiatry. 1985;42:1072-1077.
47. Robins E, Guze SB. Classification of affective disorders: the primary-secondary, the endogenous-reactive, and the neurotic-psychotic concepts. In: Williams TA, Katz MM, Shields JA, eds. Recent Advances in Psychobiology of the Depressive illnesses: Proceedings of a Workshop Sponsored by the National Institute of Mental Health. Washington, DC: Dept of Health, Education, and Welfare; 1972;283-293.
48. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
49. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry. 1992;53:364-369.
50. Hesselbrock VN, Meyer RE, Keene JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry. 1985;42:1050-1055.
51. Longabaugh R, Rubin A, Malloy P, Beattie M, Clifford PR, Noel N. Drinking outcomes of alcohol abusers diagnosed as antisocial personality disorder. Alcohol Clin Exp Res. 1994;18:778-785.
52. Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. Drug Alcohol Depend. 1990;26:39-44.
53. Gill K, Nolimal D, Crowley T. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug Alcohol Depend. 1992;30:247-252.
54. Compton WM, Cottler LB, Shillington AM, Price RK. Is antisocial personality disorder associated with increased HIV risk behaviors in cocaine users? Drug Alcohol Depend. 1995;37:37-44.
55. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry. 1993;150:53-58.
56. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259-1264.
57. Miller TR. The psychotherapeutic utility of the five-factor model of personality: a clinician's experience. Subst Use Misuse. 1991;57:415-433.
58. Rounsaville BJ, Wilber CH, Rosenberger D, Kleber HD. Comparison of opiate addicts' reports of psychiatric history with reports of significant other informants. Am J Drug Alcohol Abuse. 1981;8:51-69.
59. Alterman AI, Cacciola JS. The antisocial personality disorder diagnosis in substance abusers: problems and issues. J Nerv Ment Dis. 1991;179:401-409.
60. Brooner RK, Schmidt CW, Felch L, Bigelow GE. Antisocial behavior of intravenous drug abusers: implications for diagnosis of antisocial personality disorder. Am J Psychiatry. 1992;149:482-487.
61. Cottler LJ, Price RK, Compton WM, Mager DE. Subtypes of adult antisocial behavior among drug abusers. J Nerv Ment Dis. 1995;183:154-161.
62. Strain EC. Antisocial personality disorder, misbehavior, and drug abuse. J Nerv Ment Dis. 1995;183:162-165.
63. Institute of Medicine. In: Rettig RA, Yarmolinsky A. eds. Federal Regulations of Methadone Treatment. Washington, DC: National Academy Press; 1995.
64. Kosten TR, Rounsaville BJ, Kleber HD. Antecedents and consequences of cocaine abuse among opioid addicts: a 2.5-year follow-up. J Nerv Ment Dis. 1988;176:176-181.
65. Arndt I, Dorozynsky L, Woody GE, McLellan AT, O'Brien C. Desipramine treatment of cocaine dependence in methadone-mamtained patients. Arch Gen Psychiatry. 1992;49:888-893.
66. Meyer RE. New pharmacotherapies for cocaine dependence revisited. Arch Gen Psychiatry. 1992;49:900-904.
67. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561-565.
68. Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend. 1995;37:23-28.
69. Bux DA, Lamb RJ, Iguchi MY. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995;37:29-35.
70. McLellan AT, Woody GE, Luborsky L, O'Brien CP, Druley KA. Increased effectiveness of substance abuse treatment: a prospective study of patient-treatment matching. J Nerv Ment Dis. 1983;171:597-605.
71. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:953-959.
72. Rounsaville BJ, Glazer W, Wilber CH, Weissman MM, Kleber HD. Short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Arch Gen Psychiatry. 1983;40:629-636.
73. Woody GE, McLellan AT, Luborsky L, O'Brien CP, Blaine J, Fox S, Herman I, Beck AT. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn Study. Am J Psychiatry. 1984;141:1172-1177.
74. Woody GE, McLellan AT, Luborsky I, O'Brien CP. Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiatry. 1987;44:590-596.
75. Alterman AI, McLellan AT, Shifman RB. Do substance abuse patients with more psychopathology receive more treatment? J Nerv Ment Dis. 1993;181:576-582.
76. Kadden RM, Cooney NL, Getter H, Litt MD. Matching alcoholics to coping skills or interactional therapies: two-year follow-up results. J Consult Clin Psychol. 1991;59:598-601.
77. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol. 1992;60:927-934.
78. Stitzer ML, Higgins ST. Behavioral treatment of drug and alcohol abuse. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1994.
79. Kidorf M, Stitzer ML. Contingent access to methadone maintenance treatment: effects on cocaine use of mixed opiate-cocaine abusers. Exp Clin Psychopharm. 1993;1:200-206.
80. Kidorf M, Stitzer ML, Brooner RK, Goldberg J. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend. 1994;36:221-226.
81. Azrin NH, McMahon PT, Donohue B, Besalel VA, Lapinski KJ, Kogan ES, Acierno RE, Galloway E. Behavior therapy for drug abuse: a controlled treatment outcome study. Behav Res Ther. 1994;32:857-866.
82. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry. 1994;51:568-576.
83. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in intravenous polydrug abusers through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53:409-417.
84. Woody GE, O'Brien CP, Rickels K. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. Am J Psychiatry. 1975;132:447-450.
85. Titievsky J, Seco G, Barranco M, Kyle EM. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study. J Clin Psychiatry. 1982;43:454-456.
86. Brooner RK, Kidorf M, King VL, Bigelow GE. Preliminary results from a controlled clinical trial of behavior therapy for antisocial opioid abusers. In: Harris LS, ed, National Institute on Drug Abuse Research Monograph: Proceedings of the 56th Annual Meeting of the College on Problems of Drug Dependence. Washington, DC: Dept of Health and Human Services; 1995:213.